Research To Practice | Oncology Videos

Featuring perspectives from Dr Matthew Gubens , including the following topics: Investigator perspectives on emerging findings with immunotherapy for resectable non-small cell lung cancer (NSCLC) (0:00) Immunotherapy for early-stage unresectable disease (7:51) First-line therapy for patients with metastatic NSCLC with and without targetable mutations (17:46) Current and potential roles of antibody...

Featuring a slide presentation and related discussion from Dr Matthew Gubens, including the following topics: Early-stage non-small cell lung cancer (NSCLC) with an EGFR mutation (0:00) Management of metastatic NSCLC with an EGFR mutation (6:34) Prognostic and predictive implications of plasma circulating tumor DNA for first-line therapy for metastatic NSCLC with a HER2 mutation (12:18) Emerging f...

Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson , including the following topics: Introduction: Immunology of Melanoma (0:00) Melanoma (8:26) Cutaneous Squamous Cell Carcinoma (43:15) Basal Cell Carcinoma and Merkel Cell Carcinoma (52:55) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 2: Localized Melanoma and Other Types of Skin Cancer — Evan J Lipson, MD CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 1: Metastatic Melanoma — Omid Hamid, MD CME information and select publications

Featuring a slide presentation and related discussion from Dr Philip A Philip, including the following topics: Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00) Selection and sequencing of systemic therapy for patients with metastatic CRC (11:48) Prevalence of claudin-18.2 in patients with locally advanced or metastatic gastric or gastroesophageal junction...

Featuring an interview with Dr Philip A Philip , including the following topics: Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00) Selection of first-line therapy for patients with metastatic CRC (mCRC) (7:51) Therapeutic options for patients with HER2-positive mCRC (10:10) Patient selection for regorafenib and/or TAS-102 with or without bevacizumab for mC...

Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Susan F Slovin, including the following topics: Introduction: Current landscape of prostate cancer treatment (0:00) Relevance of homologous recombination repair mutations in castration-resistant prostate cancer: Treatment with PARP inhibitors as monotherapy — Dr Antonarakis (12:33) Phase III PROpel a...

Featuring a slide presentation and related discussion from Dr Floor J Backes, including the following topics: Recent updates from ASCO 2023 in the management of ovarian cancer (0:00) Recent updates from ASCO 2023 in the management of endometrial cancer (36:08) Recent updates from ASCO 2023 in the management of cervical cancer (41:48) CME information and select publications

Featuring perspectives from Dr Floor J Backes, including the following topics: Available data with and clinical investigator perspectives on trastuzumab deruxtecan for the management of gynecologic cancers (0:00) Patient-specific factors guiding treatment selection and sequencing for ovarian cancer (OC) (6:05) Management of adverse events associated with PARP inhibitor maintenance therapy for OC;...

Featuring perspectives from Dr Terence Friedlander and Prof Petros Grivas, including the following topics: Introduction (00:00) First-line treatment of metastatic urothelial bladder cancer (22:39) Second-line therapy and beyond (41:34) CME information and select publications

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer | Faculty Presentation 1: Immunotherapy-Based Strategies for Metastatic Urothelial Bladder Cancer (mUBC) — Terence Friedlander, MD CME information and select publications

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer | Faculty Presentation 2: Available Data with, Ongoing Investigation of and Role of Other Novel Strategies for mUBC — Petros Grivas, MD, PhD CME information and select publications

Featuring perspectives from Dr Heather McArthur , including the following topics: Investigator perspectives on recently presented data from clinical trials for HER2-positive localized and metastatic breast cancer (mBC) (0:00) Racial and ethnic differences in 21-gene Recurrence Score® and survival among patients with ER-positive breast cancer (28:31) Emerging data with CDK4/6 inhibitors for ER-posi...

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes — Faculty Presentation 2: Future directions in the management of higher-risk MDS  — Dr David Sallman CME information and select publications

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes — Faculty Presentation 1: Current management of higher-risk myelodysplastic syndromes (MDS) — Guillermo Garcia-Manero, MD CME information and select publications  

Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman, including the following topics: Introduction (00:00) Biology of Acute Myeloid Leukemia/Myelodysplastic Syndromes (3:14) Assessment of Risk Status (14:17) Oral Hypomethylating Agents (HMAs) (22:24) HMA/Venetoclax; Other Combinations (31:26) Magrolimab/TP53 (45:12) CME information and select publications  

Featuring a slide presentation and related discussion from Dr Hanny Al-Samkari, including the following topics: Indications for initiation of treatment for patients with immune thrombocytopenia (ITP) and selection of first-line therapy (0:00) Treatment algorithm for ITP in the second line and beyond (7:47) Role of thrombopoietin receptor agonists and fostamatinib for second- and later-line treatme...

Featuring perspectives from Dr Hanny Al-Samkari, including the following topics: Case: A woman in her mid 60s with a past medical history of hypertension and Sjögren's syndrome presents to emergency with diffuse petechiae in her extremities and the taste of iron in her mouth (0:00) Case: A man in his early 30s with chronic immune thrombocytopenia (ITP) who has been off therapy for 18 months with n...

Featuring perspectives from Ms Kristen B Battiato and Dr Jennifer Woyach, including the following topics: Introduction (0:00) Case: A woman in her early 70s responding to ibrutinib for 4 years (27:07) Case: A woman in her early 80s with TP53-mutant, del(17p) disease responding to acalabrutinib (38:02) Case: A man in his mid 50s with chronic lymphocytic leukemia/small lymphocytic leukemia treated f...

Featuring perspectives from Dr Carlos M de Castro , including the following topics: Overview of paroxysmal nocturnal hemoglobinuria (PNH) (0:00) Complement C5 inhibition for patients with PNH (6:48) Proximal complement inhibitors for PNH management (17:17) CME information and select publications

Featuring perspectives from Dr Carlos M de Castro , including the following topics: Biology of paroxysmal nocturnal hemoglobinuria (PNH) (0:00) Evolution of the PNH treatment landscape (13:07) Selection and sequencing of therapies for patients with PNH (18:09) Overview and presentation of extravascular hemolysis (23:50) Case: A woman in her early 40s with PNH who developed Budd-Chiari syndrome and...

Featuring perspectives from Dr David F McDermott and Dr Sumanta Kumar Pal , including the following topics: Introduction (0:00) ASCO 2023 (1:35) Management of Advanced Renal Cell Carcinoma (RCC) (17:19) Treatment Approaches for Nonmetastatic RCC; Optimal Care of Patients with Non-Clear Cell RCC (38:13) CME information and select publications

Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell, including the following topics: Introduction (0:00) First-Line Therapy for Advanced Endometrial Cancer (EC) — Dr Powell (7:32) Current Options for Relapsed EC; Promising Investigational Agents and Strategies — Dr Monk (32:39) Clinical Investigator Survey (43:41) CME information and select publications

Featuring perspectives from Dr Yelena Y Janjigian, Dr Manish A Shah and Dr Harry H Yoon , including the following topics: Integration of Immune Checkpoint Inhibitors into the Management of HER2-Negative Gastroesophageal (GE) Cancers Introduction (0:00) Adjuvant immunotherapy for GE cancers (1:54) First-line anti-PD-1/PD-L1 antibody-based regimens for metastatic HER2-negative GE cancer (13:11) Futu...